Zu den Deals
Private Equity | Gesundheitswesen | Technologie, Medien und Telekommunikation

RVC Medical IT has been acquired by NEXUS AG

Main Capital Partners B.V. has sold RVC Medical IT B.V. to NEXUS AG.

RVC Medical IT is an innovative independent software vendor offering a comprehensive healthcare enterprise imaging software suite. RVC’s product range comprises specialized front-end client software for diagnostic workstations of radiology and all medical specialties outside radiology, complemented with a vendor neutral archive (VNA), RVC clinical repository, which can store all types of images (DICOM and Non-DICOM), documents, data and signals. Notable customers include Isala, UMC Utrecht, Tergooi, Kliniken des Landeskreises Lörrach and UZ Gent. The company is headquartered in Amersfoort, the Netherlands and employs more than 70 people. It has a market share of around 53% and a customer base of 41 hospitals.

Headquartered in Germany and with over 1,300 employees, NEXUS is a leading European healthcare software company and provider of hospital and diagnostic information systems.

Main Capital is a strategic investor with an exclusive focus on the software sector in the Benelux, DACH and Nordics regions. The firm has a long-term strategy of forming successful partnerships with management teams, with the aim of building larger software groups together. Main Capital has over US$1 billion in assets under management for investments in mature and growing software companies.

Oaklins’ team in the Netherlands advised the shareholders of RVC Medical IT.

Parteien

Sprechen Sie mit dem Deal-Team

Robert Boersma

Partner
Amsterdam, Niederlande
Oaklins Netherlands

Frederik van der Schoot

Geschäftsführender Partner
Amsterdam, Niederlande
Oaklins Netherlands

Martijn de Win

Director
Amsterdam, Niederlande
Oaklins Netherlands

Robbert Bon

Senior Associate
Amsterdam, Niederlande
Oaklins Netherlands

Relevante Transaktionen

Lindenhofgruppe has sold its majority stake in LabPoint to Affidea Switzerland
Gesundheitswesen

Lindenhofgruppe has sold its majority stake in LabPoint to Affidea Switzerland

LabPoint Medical Laboratories AG has been acquired by Affidea Switzerland AG. Through the transaction, Lindenhofgruppe AG gains a strong strategic partner to support the further development of LabPoint and will remain a shareholder with a reduced stake, continuing as a key customer of the company. It lays the foundation for LabPoint’s sustainable development under a new anchor shareholder, with the aim of further strengthening and selectively expanding its position in laboratory diagnostics.

Weitere Informationen
Armira has signed an agreement to acquire a majority stake in Viabus
Private Equity | Konsumgüter & Handel

Armira has signed an agreement to acquire a majority stake in Viabus

Armira, a Germany-based investment firm, has signed an agreement to acquire a majority stake in Viabus, a leading Dutch tour operator focused on senior and young senior travelers.

Weitere Informationen
Triscan has joined APA and Riverarch to accelerate growth in the European aftermarket
Private Equity | Automobilindustrie

Triscan has joined APA and Riverarch to accelerate growth in the European aftermarket

Triscan AS, a leading provider of OE-quality automotive spare parts for the professional aftermarket in Europe, has been acquired by APA Industries, LLC, a portfolio company of Riverarch Equity Partners.

Weitere Informationen